World's Best Scientists 2026 revealed!
Stephan Rosenkranz

Stephan Rosenkranz

D-Index & Metrics

Medicine

D-Index
86
Citations
35695
World Ranking
13925
National Ranking
736

Stephan Rosenkranz publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Stephan Rosenkranz sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 450 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Stephan Rosenkranz D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Stephan Rosenkranz sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Stephan Rosenkranz is affiliated with the University of Cologne in Germany and has an extensive publication record primarily in the fields of medicine, with a particular focus on pulmonary and respiratory medicine as well as cardiology and cardiovascular medicine. Their research spans various subfields including internal medicine, genetics, and epidemiology.

The main topics covered in Rosenkranz's work include:

  • Pulmonary Hypertension Research and Treatments
  • Cardiovascular Function and Risk Factors
  • Heart Failure Treatment and Management
  • Cardiovascular Issues in Pregnancy
  • Venous Thromboembolism Diagnosis and Management
  • Vascular Anomalies and Treatments
  • Liver Disease and Transplantation

Rosenkranz has contributed to numerous publications in reputable medical journals, with frequent appearances in:

  • European Heart Journal
  • European Respiratory Journal
  • The Journal of Heart and Lung Transplantation
  • CHEST Journal
  • Pulmonary Circulation

Some of the recent notable papers associated with this researcher include:

  • "2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension," published in 2022 in the European Heart Journal
  • "COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up," published in 2020 in the Journal of the American College of Cardiology
  • "2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension," published in 2022 in the European Respiratory Journal
  • "Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study," published in 2021 in The Lancet Regional Health - Europe
  • "Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension," published in 2023 in the New England Journal of Medicine

Collaboration forms a significant part of Rosenkranz's research activities. Frequent co-authors include:

  • Hossein Ardeschir Ghofrani
  • Marius M. Hoeper
  • Ekkehard Grünig
  • Anton Vonk Noordegraaf
  • Stephan Baldus

Best Publications

  • COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

    Behnood Bikdeli;Mahesh V. Madhavan;David Jimenez;Taylor Chuich

  • TGF-β1 and angiotensin networking in cardiac remodeling

    Stephan Rosenkranz

  • Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study.

    Max Augustin;Philipp Schommers;Melanie Stecher;Felix Dewald

  • Left ventricular heart failure and pulmonary hypertension.

    Stephan Rosenkranz;J. Simon R. Gibbs;J. Simon R. Gibbs;Rolf Wachter;Teresa De Marco

  • Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model

    Marius M Hoeper;Tilmann Kramer;Zixuan Pan;Christina A Eichstaedt

  • Pulmonary arterial hypertension: epidemiology and registries

    Michael D. McGoon;Raymond L. Benza;Pilar Escribano-Subias;Xin Jiang

  • Estrogen Modulates AT1 Receptor Gene Expression In Vitro and In Vivo

    Georg Nickenig;Anselm T. Bäumer;Christian Grohè;Stefan Kahlert

  • Pulmonary hypertension due to left heart disease.

    Jean Luc Vachiéry;Ryan J. Tedford;Stephan Rosenkranz;Massimiliano Palazzini

  • Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: Results from the COMPERA registry

    Marius M. Hoeper;Doerte Huscher;H. Ardeschir Ghofrani;Marion Delcroix

  • Anticoagulation and Survival in Pulmonary Arterial Hypertension Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)

    Karen M. Olsson;Marion Delcroix;H. Ardeschir Ghofrani;Henning Tiede

  • Alterations of β-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-β1

    Stephan Rosenkranz;Markus Flesch;Kerstin Amann;Claudia Haeuseler

  • Optimizing Engineered Heart Tissue for Therapeutic Applications as Surrogate Heart Muscle

    Hiroshi Naito;Ivan Melnychenko;Michael Didié;Karin Schneiderbanger

  • Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study.

    Diana Bonderman;Ingrid Pretsch;Regina Steringer-Mascherbauer;Pavel Jansa

  • Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum

    Christian F. Opitz;Marius M. Hoeper;J. Simon R. Gibbs;Harald Kaemmerer

  • Evidence for distinct signaling properties and biological responses induced by the PDGF receptor alpha and beta subtypes

    Stephan Rosenkranz;Andrius Kazlauskas

  • Safety and Efficacy of Exercise Training in various forms of Pulmonary Hypertension

    Ekkehard Grünig;Mona Lichtblau;Nicola Ehlken;Hossein A Ghofrani

  • Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.

    Hossein Ardeschir Ghofrani;Hossein Ardeschir Ghofrani;Gérald Simonneau;Gérald Simonneau;Andrea M. D'Armini;Peter Fedullo

  • Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial

    Nicola Ehlken;Mona Lichtblau;Hans Klose;Johannes Weidenhammer

  • An official European Respiratory Society statement: pulmonary haemodynamics during exercise

    Gabor Kovacs;Philippe Herve;Joan Albert Barbera;Ari Chaouat

  • Guía ESC/ERS 2015 sobre diagnóstico y tratamiento de la hipertensión pulmonar

    Nazzareno Galiè;Marc Humbert;Jean Luc Vachiery;Simon Gibbs

Frequent Co-Authors

Marius M. Hoeper
Marius M. Hoeper Hannover Medical School
Hossein Ardeschir Ghofrani
Hossein Ardeschir Ghofrani University of Giessen
Erland Erdmann
Erland Erdmann University of Cologne
Stephan Baldus
Stephan Baldus University of Cologne
Gérald Simonneau
Gérald Simonneau University of Paris-Saclay
Horst Olschewski
Horst Olschewski Medical University of Graz
Ralph T. Schermuly
Ralph T. Schermuly University of Giessen
Stavros Konstantinides
Stavros Konstantinides Democritus University of Thrace
Marc Humbert
Marc Humbert University of Paris-Saclay
Oliver Distler
Oliver Distler University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a medical career in the USA but want flexible study options, many affordable nursing degrees can be pursued online. For those new to healthcare, there are a range of online nursing programs that open doors to entry-level roles in hospitals, clinics, and community settings.

Registered nurses (RNs) looking to advance can explore the cheapest accredited online RN to BSN programs. These bridge courses help RNs earn their BSN quickly and affordably, which can improve job prospects and earning potential.

For career changers with non-nursing backgrounds, online direct entry MSN degrees allow you to transition into advanced practice by earning both RN licensure and a master’s degree in one streamlined program.

Already an experienced nurse? Enhance your credentials and move into education, research, or leadership with an online PhD in nursing. Online learning makes it easier to upskill without putting your career on hold, supporting a variety of pathways in healthcare and medicine.

Best Scientists Citing Stephan Rosenkranz

Trending Scientists

Recently Published Articles